Skip to main content
Erschienen in: Pediatric Radiology 13/2017

08.09.2017 | Original Article

FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients

verfasst von: Susan E. Sharp, Barry L. Shulkin, Michael J. Gelfand, M. Beth McCarville

Erschienen in: Pediatric Radiology | Ausgabe 13/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Osteosarcoma is the most common pediatric malignant bone tumor, frequently surgically managed with limb salvage rather than amputation. Local recurrences are seen in up to 9% of osteosarcoma patients, with CT and MRI imaging often limited by metal artifacts.

Objective

To describe the [F-18]2-fluoro-2-deoxyglucose (FDG) PET/CT appearance of local osteosarcoma recurrences with correlation to findings on other imaging modalities.

Materials and methods

A retrospective review of pediatric osteosarcoma patients imaged with FDG PET/CT was performed in patients with pathologically proven local recurrences. FDG PET/CT findings were reviewed and correlated with available comparison imaging studies.

Results

Ten local osteosarcoma recurrences in eight pediatric osteosarcoma patients were imaged with FDG PET/CT. All eight patients had a local recurrence after limb salvage; two patients had a second local recurrence after amputation. All local recurrences were seen with FDG PET/CT, demonstrating solid (n=5) or peripheral/nodular (n=5) FDG uptake patterns. Maximum standard uptake values (SUVs) ranged from 3.0 to 15.7. In five recurrences imaged with FDG PET/CT and MRI, MRI was limited or nondiagnostic in three. In four recurrences imaged with FDG PET/CT and bone scan, the bone scan was negative in three.

Conclusion

Local osteosarcoma recurrences are well visualized by FDG PET/CT, demonstrating either solid or peripheral/nodular FDG uptake with a wide range of maximum SUVs. FDG PET/CT demonstrates the full extent of local recurrences, while MRI can be limited by artifact from metallic hardware. PET/CT appears to be more sensitive than bone scan in detecting local osteosarcoma recurrences.
Literatur
2.
Zurück zum Zitat Bacci G, Longhi A, Fagioli F et al (2005) Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli institute, Italy. Eur J Cancer 41:2836–2845CrossRefPubMed Bacci G, Longhi A, Fagioli F et al (2005) Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli institute, Italy. Eur J Cancer 41:2836–2845CrossRefPubMed
3.
Zurück zum Zitat Janeway KA, Barkauskas DA, Krailo MD et al (2012) Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children’s Oncology Group. Cancer 118:4597–4605 Janeway KA, Barkauskas DA, Krailo MD et al (2012) Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children’s Oncology Group. Cancer 118:4597–4605
4.
Zurück zum Zitat Leary SE, Wozniak AW, Billups CA et al (2013) Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children’s Research Hospital experience. Cancer 119:2645–2653CrossRefPubMedPubMedCentral Leary SE, Wozniak AW, Billups CA et al (2013) Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children’s Research Hospital experience. Cancer 119:2645–2653CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kempf-Bielack B, Bielack SS, Jürgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (COSS). J Clin Oncol 23:559–568CrossRefPubMed Kempf-Bielack B, Bielack SS, Jürgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (COSS). J Clin Oncol 23:559–568CrossRefPubMed
6.
Zurück zum Zitat Bacci G, Briccoli A, Longhi A et al (2005) Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 44:748–755CrossRefPubMed Bacci G, Briccoli A, Longhi A et al (2005) Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 44:748–755CrossRefPubMed
7.
Zurück zum Zitat Rodriguez-Galindo C, Shah N, McCarville MB et al (2004) Outcome after local recurrence of osteosarcoma: the St. Jude Children’s Research Hospital experience (1970-2000). Cancer 100:1928–1935 Rodriguez-Galindo C, Shah N, McCarville MB et al (2004) Outcome after local recurrence of osteosarcoma: the St. Jude Children’s Research Hospital experience (1970-2000). Cancer 100:1928–1935
8.
Zurück zum Zitat Weeden S, Grimer RJ, Cannon SR et al (2001) The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 37:39–46CrossRefPubMed Weeden S, Grimer RJ, Cannon SR et al (2001) The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 37:39–46CrossRefPubMed
9.
Zurück zum Zitat Bacci G, Longhi A, Cesari M et al (2006) Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106:2701–2706CrossRefPubMed Bacci G, Longhi A, Cesari M et al (2006) Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106:2701–2706CrossRefPubMed
10.
Zurück zum Zitat Loh AH, Navid F, Wang C et al (2014) Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol 21:1948–1955CrossRefPubMedPubMedCentral Loh AH, Navid F, Wang C et al (2014) Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol 21:1948–1955CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790CrossRefPubMed Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790CrossRefPubMed
12.
Zurück zum Zitat Gelfand MJ, Sharp SE (2015) [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography after limb salvage surgery: post-surgical appearance, attenuation correction and local complications. Pediatr Radiol 45:1182–1188CrossRefPubMed Gelfand MJ, Sharp SE (2015) [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography after limb salvage surgery: post-surgical appearance, attenuation correction and local complications. Pediatr Radiol 45:1182–1188CrossRefPubMed
13.
Zurück zum Zitat Chang KJ, Kong CB, Cho WH et al (2015) Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement. Skeletal Radiol 44:529–537 Chang KJ, Kong CB, Cho WH et al (2015) Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement. Skeletal Radiol 44:529–537
14.
Zurück zum Zitat Sharma P, Khangembam BC, Suman KC et al (2013) Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Eur J Nucl Med Mol Imaging 40:1036–1043CrossRefPubMed Sharma P, Khangembam BC, Suman KC et al (2013) Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Eur J Nucl Med Mol Imaging 40:1036–1043CrossRefPubMed
15.
Zurück zum Zitat Arush MW, Israel O, Postovsky S et al (2007) Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer 49:901–906CrossRefPubMed Arush MW, Israel O, Postovsky S et al (2007) Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer 49:901–906CrossRefPubMed
16.
Zurück zum Zitat Franzius C, Daldrup-Link HE, Wagner-Bohn A et al (2002) FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13:157–160CrossRefPubMed Franzius C, Daldrup-Link HE, Wagner-Bohn A et al (2002) FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13:157–160CrossRefPubMed
17.
Zurück zum Zitat Byun BH, Kong CB, Lim I et al (2013) Comparison of (18)F-FDG PET/CT and (99m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal Radiol 42:1673–1681 Byun BH, Kong CB, Lim I et al (2013) Comparison of (18)F-FDG PET/CT and (99m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal Radiol 42:1673–1681
18.
Zurück zum Zitat Hurley C, McCarville MB, Shulkin BL et al (2016) Comparison of (18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma. Pediatr Blood Cancer 63:1381–1386CrossRefPubMedPubMedCentral Hurley C, McCarville MB, Shulkin BL et al (2016) Comparison of (18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma. Pediatr Blood Cancer 63:1381–1386CrossRefPubMedPubMedCentral
Metadaten
Titel
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients
verfasst von
Susan E. Sharp
Barry L. Shulkin
Michael J. Gelfand
M. Beth McCarville
Publikationsdatum
08.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 13/2017
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-017-3963-1

Weitere Artikel der Ausgabe 13/2017

Pediatric Radiology 13/2017 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.